Diagnosis of primary ciliary dyskinesia (PCD) lacks a “gold standard” test and is therefore
based on combinations of tests including nasal nitric oxide (nNO), high-speed video …

Primary ciliary dyskinesia is a genetic disease of ciliary function leading to chronic upper
and lower respiratory tract symptoms. The diagnosis is frequently overlooked because the …

Significant advances have been made in the diagnosis of patients with primary ciliary
dyskinesia (PCD) including centralised services [ 1–3], European consensus guidelines [4] …

The diagnosis of primary ciliary dyskinesia is often confirmed with standard, albeit complex
and expensive, tests. In many cases, however, the diagnosis remains difficult despite the …

Rationale: Primary ciliary dyskinesia (PCD) is a rare disorder causing chronic
otosinopulmonary disease, generally diagnosed through evaluation of respiratory ciliary …

Primary ciliary dyskinesia (PCD) is a rare genetic disorder of ciliary structure and function.
The diagnosis can be challenging, particularly when using nongenetic assays. The “gold …

Diagnosing primary ciliary dyskinesia is difficult. With no reference standard, a combination
of tests is needed; most tests require expensive equipment and specialist scientists. We …

Background Nasal nitric oxide (nNO) levels are very low in primary ciliary dyskinesia (PCD)
and it is used as a screening test. Methods We assessed the reliability and usability of a …

Rationale: Primary ciliary dyskinesia (PCD) is a heterogeneous, multisystem disorder
characterized by defective ciliary beating. Diagnostic guidelines of the American Thoracic …

Nasal nitric oxide (nNO) has a well-known potential as an indirect discriminative marker
between patients with primary ciliary dyskinesia (PCD) and healthy subjects, but real-life …